Most people who are familiar with Signer Harris Architects know Jane Kepros as knowledgeable and detailed lab programmer and planner – but prior to joining Signer Harris Architects, Jane was a scientific researcher at Synta Pharmaceuticals. It is there that she co-authored a paper titled “Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol” and we are pleased to announce that the paper was just published in PLoS (Public Library of Science) One!
Our other in-house biologist, Associate Jeannie Pierce Thacker, is the only one in our office who understands everything Jane wrote, but we can all recognize the hard work and dedication that Jane contributed to the paper, and we are proud of her accomplishment. That is why we wanted to share this news with those of you who have had the opportunity to work with her, and we have included a link to download the paper for those of you who understand the science.
To download the paper, click here.
